Long-acting β2-agonists increase fluticasone propionate-induced mitogen-activated protein kinase phosphatase 1 (MKP-1) in airway smooth muscle cells.
about
Glucocorticoid-independent modulation of GR activity: Implications for immunotherapySphingosine 1-phosphate induces neutrophil chemoattractant IL-8: repression by steroids.Salmeterol Efficacy and Bias in the Activation and Kinase-Mediated Desensitization of β2-Adrenergic Receptors.Anti-Inflammatory Effects of β2-Receptor Agonists Salbutamol and Terbutaline Are Mediated by MKP-1.Effect of the plant derivative Compound A on the production of corticosteroid-resistant chemokines in airway smooth muscle cells.Early achievement and maintenance of stable asthma control using initially higher-dose inhaled corticosteroids as part of combination therapy: an open-label pilot study.Inhibition of phosphodiesterase 4 modulates cytokine induction from toll like receptor activated, but not rhinovirus infected, primary human airway smooth muscle.Understanding how long-acting β2 -adrenoceptor agonists enhance the clinical efficacy of inhaled corticosteroids in asthma - an update.Temporal regulation of cytokine mRNA expression by tristetraprolin: dynamic control by p38 MAPK and MKP-1.TLR2 activation causes tachyphylaxis to β2 -agonists in vitro and ex vivo: modelling bacterial exacerbation.Role and regulation of MKP-1 in airway inflammation.Inhibitors of Phosphodiesterase 4, but Not Phosphodiesterase 3, Increase β2-Agonist-Induced Expression of Antiinflammatory Mitogen-Activated Protein Kinase Phosphatase 1 in Airway Smooth Muscle Cells.Roflumilast N-Oxide in Combination with Formoterol Enhances the Antiinflammatory Effect of Dexamethasone in Airway Smooth Muscle Cells.Theophylline Represses IL-8 Secretion from Airway Smooth Muscle Cells Independently of Phosphodiesterase Inhibition. Novel Role as a Protein Phosphatase 2A Activator.Corticosteroid-Induced MKP-1 Represses Pro-Inflammatory Cytokine Secretion by Enhancing Activity of Tristetraprolin (TTP) in ASM Cells.
P2860
Q28077040-8E09CDEA-5127-4CA5-B318-F0B3D54CA630Q35125221-D51A57BD-B7FC-48E1-990A-B34EBB10EEA3Q35600398-4125E4EF-12E5-4B55-8C24-FEB3CF472770Q35915798-AA390AF9-685D-4867-B091-B8A8C8580955Q36549178-B0FA7191-2AEE-4970-826C-2A7ADB12F2C5Q36954589-C07BCDC6-8096-4C13-AEE7-F18A309D1389Q37320983-C3FADE77-5EB5-4703-8E55-04F76EDA6A39Q38959067-3FB8DD73-A32A-4002-A82C-F1190C83F6BDQ39034638-D3D2279D-14E9-4EC4-A69A-B5FBCC93C920Q39186404-3BC268C7-124D-46B9-A215-C150AA7B046AQ41365375-69442CA7-955A-4C77-8EF7-70D48AA1D242Q46038615-C6F8DDD7-27A8-4D53-B69A-5E5481A95FCCQ48015606-4A526CB5-D81A-4A7F-900E-E5F53F9A7C7BQ51573670-2C0CA553-2BB3-4711-AEAB-544B3A865A0BQ55031478-0E5C807A-7AC0-4395-8814-E7EEFA81F1F3
P2860
Long-acting β2-agonists increase fluticasone propionate-induced mitogen-activated protein kinase phosphatase 1 (MKP-1) in airway smooth muscle cells.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մարտին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Long-acting β2-agonists increa ...... in airway smooth muscle cells.
@ast
Long-acting β2-agonists increa ...... in airway smooth muscle cells.
@en
Long-acting β2-agonists increa ...... d protein kinase phosphatase 1
@nl
type
label
Long-acting β2-agonists increa ...... in airway smooth muscle cells.
@ast
Long-acting β2-agonists increa ...... in airway smooth muscle cells.
@en
Long-acting β2-agonists increa ...... d protein kinase phosphatase 1
@nl
prefLabel
Long-acting β2-agonists increa ...... in airway smooth muscle cells.
@ast
Long-acting β2-agonists increa ...... in airway smooth muscle cells.
@en
Long-acting β2-agonists increa ...... d protein kinase phosphatase 1
@nl
P2093
P2860
P1433
P1476
Long-acting β2-agonists increa ...... in airway smooth muscle cells
@en
P2093
Brijeshkumar S Patel
Hatem Alkhouri
Md Mostafizur Rahman
Melanie Manetsch
Nowshin N Rumzhum
P2860
P304
P356
10.1371/JOURNAL.PONE.0059635
P407
P577
2013-03-22T00:00:00Z